Acer Therapeutics Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2011 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Acer Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q1 2023.
- Acer Therapeutics Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$9.02M, a 199% decline year-over-year.
- Acer Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$30.3M, a 22324% decline from 2021.
- Acer Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$135K, a 99.2% increase from 2020.
- Acer Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$17M, a 42.3% increase from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)